1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Acurx Pharmaceuticals, Inc.

Acurx Pharmaceuticals, Inc.

ACXP
Acurx Pharmaceuticals, Inc.US flagNASDAQ Capital Market
1.52
USD
-0.03
- -
2.41MMarket Cap

Income Statement (USD)

APIChatGPT
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
6
5
13
12
15
14
8
+ Selling, General & Admin
2
2
11
7
9
9
6
+ Research & Development
4
2
2
5
6
5
2
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-6
-5
-13
-12
-15
-14
-8
- Non-Operating (Income) Loss
- -
- -
- -
- -
- -
- -
- -
+ Interest Expense, Net
- -
- -
- -
- -
- -
- -
- -
+ Interest Expense
- -
- -
- -
- -
- -
- -
- -
- Interest Income
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
- -
- -
- -
- -
- -
- -
- -
Pretax Income
-6
-5
-13
-12
-15
-14
-8
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-6
-5
-13
-12
-15
-14
-8
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-6
-5
-13
-12
-15
-14
-8
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-6
-5
-13
-12
-15
-14
-8
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-6
-5
-13
-12
-15
-14
-8
EBIT
-6
-5
-13
-12
-15
-14
-8
EBITDA
-6
-5
-13
-12
-15
-14
-8
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
EBITA
-6
-5
-13
-12
-15
-14
-8
Gross Margin (%)
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
- -
- -
- -
1
1
1
1
Basic EPS, GAAP
-15.81
-9.64
-29.87
-22.36
-23.01
-17.45
-5.32
Basic EPS from Cont Ops
-15.81
-9.64
-29.87
-22.36
-23.01
-17.45
-5.32
Diluted Weighted Avg Shares
- -
- -
- -
1
1
1
1
Diluted EPS, GAAP
-15.81
-9.64
-29.87
-22.36
-23.01
-17.45
-5.32
Diluted EPS from Cont Ops
-15.81
-9.64
-29.87
-22.36
-23.01
-17.45
-5.32

Balance Sheet (USD)

APIChatGPT
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
3
3
13
9
8
4
8
+ Cash, Cash Equivalents & STI
2
3
13
9
7
4
8
+ Cash & Cash Equivalents
2
3
13
9
7
4
8
+ ST Investments
- -
- -
- -
- -
- -
- -
- -
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
- -
- -
- -
- -
- -
+ Property, Plant & Equip, Net
- -
- -
- -
- -
- -
- -
- -
+ Property, Plant & Equip
- -
- -
- -
- -
- -
- -
- -
- Accumulated Depreciation
- -
- -
- -
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
- -
- -
- -
- -
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
- -
- -
- -
Total Assets
3
3
13
9
8
4
8
+ Payables & Accruals
- -
- -
- -
2
2
3
2
+ Accounts Payable
- -
- -
- -
- -
- -
- -
- -
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
- -
- -
2
2
3
2
+ ST Debt
- -
- -
- -
- -
- -
- -
- -
+ ST Borrowings
- -
- -
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
- -
+ Other ST Liabilities
1
- -
1
1
1
1
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
1
- -
1
1
1
1
- -
Total Current Liabilities
2
- -
1
2
3
3
2
+ LT Debt
- -
- -
- -
- -
- -
- -
- -
+ LT Borrowings
- -
- -
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
- -
+ Other LT Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Liabilities
- -
- -
- -
- -
- -
- -
- -
Total Liabilities
2
1
1
2
3
3
2
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
10
17
39
46
58
68
81
+ Common Stock
10
17
- -
- -
- -
- -
- -
+ Additional Paid in Capital
- -
- -
39
46
58
68
81
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-9
-14
-27
-39
-53
-67
-75
+ Other Equity
-9
-14
-27
-39
- -
- -
- -
Equity Before Minority Interest
1
3
12
7
5
1
5
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
Total Equity
1
3
12
7
5
1
5
Total Liabilities & Equity
3
3
13
9
8
4
8
Shares Outstanding
- -
- -
1
1
1
1
2
Number of Employees
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
- -
- -
- -
Net Debt
-2
-3
-13
-9
-7
-4
-8
Net Debt to Equity
-302.9
-115.08
-104.42
-124.56
-160.16
-602.6
-143.42
Tangible Common Equity Ratio
32.39
83.8
93.63
78.01
60.53
15.94
68.52
Current Ratio
1.48
6.82
15.71
4.55
2.53
1.19
3.18
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-6
-5
-13
-12
-15
-14
-8
+ Depreciation & Amortization
- -
- -
- -
- -
- -
- -
- -
+ Non-Cash Items
1
2
8
3
4
3
2
+ Stock-Based Compensation
1
1
7
3
4
3
2
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
1
1
- -
- -
- -
- -
+ Chg in Non-Cash Work Cap
1
-1
- -
1
1
- -
- -
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
- -
- -
- -
- -
- -
+ Inc (Dec) in Accts Payable
1
-1
- -
1
1
- -
- -
+ Inc (Dec) in Other
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-4
-3
-5
-8
-10
-10
-7
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
4
4
15
4
6
6
7
+ Increase in Capital Stock
4
4
15
4
6
6
7
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
- -
- -
- -
- -
- -
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
- -
- -
- -
- -
+ Cash From Debt
- -
- -
- -
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
- -
- -
- -
- -
2
- -
4
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
4
4
15
4
8
7
11
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
- -
1
10
-4
-2
-4
4
EBITDA
-6
-5
-13
-12
-15
-14
-8
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow
-4
-3
-5
-8
-10
-10
-7
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-3
-5
-8
-10
-10
-7
Free Cash Flow per Basic Share
-10.62
-7.03
-11.75
-13.95
-15.47
-12.85
-4.53
Price/Free Cash Flow
- -
- -
-7.36
-5.71
-4.95
-1.27
-0.55
Cash Flow to Net Income
0.67
0.73
0.39
0.62
0.67
0.74
0.85
Capital Expenditures
- -
- -
- -
- -
- -
- -
- -